Clinical Trial Update: ATS 3f(r) Aortic Bioprosthesis Model 1000 Post Approval Study [NA]

View source ↗

Summary

This clinical trial update reports results from the post-approval study of Medtronic's ATS 3f(r) Aortic Bioprosthesis Model 1000. The study was terminated and r…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aortic Valve Disease
• Valvular Heart Disease

Drugs mentioned

• ATS 3f(r) Aortic Bioprosthesis Model 1000

Snippet

Sponsor: Medtronic Cardiovascular | Conditions: Heart Valve Diseases | NA | Status: TERMINATED | Results posted: 2017-05-25